KDventures AB (publ) (Nasdaq Stockholm: KDV) today announces that the number of shares and votes has changed during June 2026 as a result of the directed issue resolved by the Board of Directors on June 18, 2026.
Today, the last trading day of the month, there are 759,044,795 shares, representing a total of 782,042,144 votes outstanding in the company, distributed among 2,555,261 shares of series A (with 25,552,610 votes) and 756,489,534 shares of series B (with 756,489,534 votes).
Contacts
Viktor Drvota, CEO, KDventures AB
Phone: +46 73 982 52 02, e-mail:
Johan Dighed, General Counsel and Deputy CEO, KDventures AB
Phone: +46 70 207 48 26, e-mail:
This information is information that KD Ventures is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-06-30 08:00 CEST.
About Us
KDventures AB (Nasdaq Stockholm: KDV) is a Nordic investment company specialized in life sciences. The company identifies and invests in innovative pharmaceutical projects and medical technology products originating from leading research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, KDventures creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with significant value growth potential.
For more information, please visit https://www.kd-ventures.com/en.
Attachments